Clover Health Investments (NASDAQ:CLOV) VP Sells $103,200.00 in Stock

Clover Health Investments, Corp. (NASDAQ:CLOV) VP Joseph Frank Oldakowski sold 20,000 shares of the company’s stock in a transaction on Monday, September 14th. The shares were sold at an average price of $5.16, for a total value of $103,200.00. Following the sale, the vice president owned 279,067 shares of the company’s stock, valued at approximately $1,439,985.72. The trade was a 6.69% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Joseph Frank Oldakowski also recently made the following trade(s):

• On Tuesday, June 16th, Joseph Frank Oldakowski sold 12,102 shares of Clover Health Investments stock. The stock was sold at an average price of $4.86, for a total transaction of $58,815.72.

Clover Health Investments Price Performance

Shares of NASDAQ CLOV traded up $0.28 during midday trading on Monday, reaching $5.10. The company’s stock had a trading volume of 5,397,714 shares, compared to its average volume of 3,434,186. The stock has a market capitalization of $2.71 billion, a P/E ratio of -101.98 and a beta of 2.47. The firm has a 50 day moving average price of $4.43 and a 200-day moving average price of $3.55. Clover Health Investments, Corp. has a 12-month low of $1.58 and a 12-month high of $5.59.

Clover Health Investments (NASDAQ:CLOV) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $0.05 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.01. Clover Health Investments had a negative return on equity of 4.20% and a negative net margin of 0.74%.The business had revenue of $743.17 million for the quarter, compared to analyst estimates of $728.27 million.

Analyst Ratings Changes

CLOV has been the subject of several research reports. Wall Street Zen lowered shares of Clover Health Investments from a “strong-buy” rating to a “buy” rating in a research report on Sunday, August 16th. Canaccord Genuity Group boosted their target price on shares of Clover Health Investments from $4.20 to $5.50 and gave the company a “buy” rating in a research note on Tuesday, July 21st. Deutsche Bank Aktiengesellschaft began coverage on shares of Clover Health Investments in a research report on Thursday. They set a “buy” rating and a $6.00 target price for the company. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Clover Health Investments in a report on Wednesday, June 24th. Finally, UBS Group upped their price objective on Clover Health Investments from $4.75 to $5.00 and gave the company a “neutral” rating in a research note on Thursday, August 6th. Two research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $4.75.

Hedge Funds Weigh In On Clover Health Investments

Large investors have recently added to or reduced their stakes in the business. ProShare Advisors LLC lifted its stake in shares of Clover Health Investments by 8.2% in the 4th quarter. ProShare Advisors LLC now owns 74,700 shares of the company’s stock valued at $176,000 after acquiring an additional 5,660 shares during the last quarter. Kestra Private Wealth Services LLC grew its holdings in shares of Clover Health Investments by 44.1% in the first quarter. Kestra Private Wealth Services LLC now owns 24,525 shares of the company’s stock worth $43,000 after purchasing an additional 7,500 shares during the last quarter. Public Employees Retirement System of Ohio purchased a new position in shares of Clover Health Investments in the second quarter worth $42,000. Nykredit A S bought a new stake in Clover Health Investments during the 2nd quarter valued at $45,000. Finally, USAdvisors Wealth Management LLC boosted its position in Clover Health Investments by 40.0% during the 1st quarter. USAdvisors Wealth Management LLC now owns 35,000 shares of the company’s stock valued at $60,000 after buying an additional 10,000 shares during the period. Hedge funds and other institutional investors own 19.77% of the company’s stock.

Clover Health Investments Company Profile

Clover Health Investments, Inc is a healthcare technology and insurance company focused on providing Medicare Advantage plans to eligible Medicare beneficiaries. Its insurance business offers medical coverage and related healthcare benefits through plans available in select counties across the United States.

The company also develops and uses Clover Assistant, a technology platform designed to support physicians with patient information, clinical insights, care recommendations and tools intended to help improve healthcare outcomes.